Howard W. Robin
2013
In 2013, Howard W. Robin earned a total compensation of $3.6M as President and Chief Executive Officer at Nektar Therapeutics, a 10% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $656,200 |
|---|---|
| Option Awards | $2,067,165 |
| Salary | $831,247 |
| Other | $15,040 |
| Total | $3,569,652 |
Robin received $2.1M in option awards, accounting for 58% of the total pay in 2013.
Robin also received $656.2K in non-equity incentive plan, $831.2K in salary and $15K in other compensation.
Rankings
In 2013, Howard W. Robin's compensation ranked 2,047th out of 12,286 executives tracked by ExecPay. In other words, Robin earned more than 83.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,047 out of 12,286 | 83rd |
Division Manufacturing | 671 out of 4,614 | 86th |
Major group Chemicals And Allied Products | 190 out of 1,466 | 87th |
Industry group Drugs | 128 out of 1,160 | 89th |
Industry Pharmaceutical Preparations | 108 out of 890 | 88th |
Source: SEC filing on April 29, 2016.
Robin's colleagues
We found four more compensation records of executives who worked with Howard W. Robin at Nektar Therapeutics in 2013.